Famotidine Injection — Class III drug recall D-1392-2020
Terminated recall by HF Acquisition Co. LLC, reported 2020-07-29. TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
| Recall number | D-1392-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | HF Acquisition Co. LLC, Mukilteo, WA, United States |
| Recall initiated | 2020-06-17 |
| Classified | 2020-07-21 |
| Reported by FDA | 2020-07-29 |
| Terminated | 2021-04-13 |
| Reason classes | temperature control |
| NDC | 63323-0739, 63323-0739-11, 63323-0739-12 |
| Lot numbers | 6122639 |
| Expiration dates | 2021-08 |
Product
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12
Reason for recall
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1392-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.